Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · IEX Real-Time Price · USD
0.835
+0.025 (3.05%)
At close: Jul 26, 2024, 4:00 PM
0.846
+0.011 (1.38%)
After-hours: Jul 26, 2024, 7:59 PM EDT
Hoth Therapeutics Employees
As of December 31, 2023, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,567,555
Market Cap
4.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Biomerica | 62 |
| PolyPid | 62 |
| Sharps Technology | 57 |
| FSD Pharma | 17 |
| Pasithea Therapeutics | 8 |
| Oragenics | 5 |
| Titan Pharmaceuticals | 4 |
| GT Biopharma | 2 |
HOTH News
- 3 days ago - Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment - PRNewsWire
- 10 days ago - Hoth Therapeutics Expands Clinical Trial for Cancer Patients - PRNewsWire
- 6 weeks ago - Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery - PRNewsWire
- 3 months ago - Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 - PRNewsWire
- 4 months ago - Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds - PRNewsWire
- 4 months ago - Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment - PRNewsWire
- 4 months ago - Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ - PRNewsWire
- 5 months ago - Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio - PRNewsWire